Reidy, M.; Khan, M.; Mills, E.A.; Wu, Q.; Garton, J.; Draayer, D.E.; Zahoor, I.; Giri, S.; Axtell, R.C.; Mao-Draayer, Y.
New Frontiers in Multiple Sclerosis Treatment: From Targeting Costimulatory Molecules to Bispecific Antibodies. Int. J. Mol. Sci. 2025, 26, 3880.
https://doi.org/10.3390/ijms26083880
AMA Style
Reidy M, Khan M, Mills EA, Wu Q, Garton J, Draayer DE, Zahoor I, Giri S, Axtell RC, Mao-Draayer Y.
New Frontiers in Multiple Sclerosis Treatment: From Targeting Costimulatory Molecules to Bispecific Antibodies. International Journal of Molecular Sciences. 2025; 26(8):3880.
https://doi.org/10.3390/ijms26083880
Chicago/Turabian Style
Reidy, Megan, Meerah Khan, Elizabeth A. Mills, Qi Wu, Josh Garton, Dean E. Draayer, Insha Zahoor, Shailendra Giri, Robert C. Axtell, and Yang Mao-Draayer.
2025. "New Frontiers in Multiple Sclerosis Treatment: From Targeting Costimulatory Molecules to Bispecific Antibodies" International Journal of Molecular Sciences 26, no. 8: 3880.
https://doi.org/10.3390/ijms26083880
APA Style
Reidy, M., Khan, M., Mills, E. A., Wu, Q., Garton, J., Draayer, D. E., Zahoor, I., Giri, S., Axtell, R. C., & Mao-Draayer, Y.
(2025). New Frontiers in Multiple Sclerosis Treatment: From Targeting Costimulatory Molecules to Bispecific Antibodies. International Journal of Molecular Sciences, 26(8), 3880.
https://doi.org/10.3390/ijms26083880